TY  - JOUR
T1  - INtravenous immunoglobulin therapy in human immunodeficiency virus—associated thrombocytopenia-reply
AU  - GREEN D
Y1  - 1989/02/01
N1  - 10.1001/archinte.1989.00390020151037
JO  - Archives of Internal Medicine
SP  - 467
EP  - 467
VL  - 149
IS  - 2
N2  - In Reply.—With regard to Fisher's letter, we agree that outpatient therapy with intravenously administered immunoglobulin is both feasible and less costly than in-hospital treatment for human immunodeficiency virus—associated thrombocytopenia. Indeed, since publication of our article, we have treated some outpatients with intravenously administered immunoglobulin in a dose of 50 g given over a six-hour period as a single infusion, repeating this dose as clinically indicated.
SN  - 0003-9926
M3  - doi: 10.1001/archinte.1989.00390020151037
UR  - http://dx.doi.org/10.1001/archinte.1989.00390020151037
ER  -